Twist Bioscience Corp reports results for the quarter ended in March - Earnings Summary

Twist Bioscience

05/05/2023 14:32

* Twist Bioscience Corp  TWST.OQ  reported a quarterly
adjusted
loss of $1.04​​ per share for the quarter ended in March. The
mean expectation of nine analysts for the quarter was for a loss
of $1.12 per share.
    * Revenue rose 25% to $60.18 million from a year ago;
analysts
expected $56.69 million. 
    * Twist Bioscience Corp's reported EPS for the quarter was a
loss
of $1.04​.
    * The mean earnings estimate of analysts had fallen by
about 0.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Twist Bioscience Corp shares had fallen by 14.2% this
quarter and lost 45.7% so far this year.
    * The company reported a quarterly loss of $59.15 million.
    * Wall Street's median 12-month price target for Twist
Bioscience
Corp is $30.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
5 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -1.12          -1.04          Beat
 Dec. 31 2022      -1.13          -0.74          Beat
 Sep. 30 2022      -1.25          -0.91          Beat
 Jun. 30 2022      -1.31          -1.08          Beat